Recipient of federal assistance · MIDDLETON, WI

VARIGEN BIOSCIENCES CORP

VARIGEN BIOSCIENCES CORP received $0 in federal grants and other assistance in FY2026, on 6 actions, −100% vs FY2025. It has no federal contracts in the loaded years. Since FY2021: $2.8M.

Assistance · FY2026
$0
New awards
0
Actions
6
Since FY2021
$2.8M
UEI
XLMBJ8BVWPZ3
Location
MIDDLETON, WI
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 399.8KFY2021
  2. 174.7KFY2022
  3. 1.1MFY2023
  4. 943.5KFY2024
  5. 174.4KFY2025
  6. 0FY2026

Top programs · Awarding agencies

Obligations in FY2026.

Largest awards

  1. ** AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF…$649.8K
    10.212 · Small Business Innovation Research (SBIR) Program / Small Business Technology Transfer (STTR) Program· National Institute of Food and Agriculture· Project grant· Sep 1, 2024 – May 20, 2026· 20243361043218
  2. SYNTHETIC BIOLOGY FOR SPLICE MODULATING POLYKETIDES - PROJECT SUMMARY. NATURAL PRODUCT-DERIVED RNA SPLICE MODULATORS ARE BEING DEVELOPED…$297.1K
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Jun 25, 2024 – Nov 28, 2025· R43CA287469
  3. A UNIVERSAL FUNGAL TRANSPOSASE SYSTEM FOR INCREASING NATURAL PRODUCT AND PROTEIN TITERS - PROJECT SUMMARY. FUNGAL NATURAL PRODUCTS (NPS)…$295.3K
    93.213 · Research and Training in Complementary and Integrative Health· National Institutes of Health· Project grant· Sep 5, 2023 – Mar 2, 2026· R43AT012434
  4. PA-21-259, SBIR, PHASE I, RAPID MOLECULAR DIAGNOSTIC ASSAY FOR DETECTION OF CANDIDA AURIS AT POINT OF CARE$252.2K
    93.283 · Centers for Disease Control and Prevention Investigations and Technical Assistance· Centers for Disease Control and Prevention· Grant· Aug 23, 2023 – Apr 27, 2026· R43CK000699
  5. RAPID MOLECULAR DIAGNOSTIC ASSAY FOR DETECTION OF HEPATITIS C VIRUS AT POINT OF CARE$252.1K
    93.283 · Centers for Disease Control and Prevention Investigations and Technical Assistance· Centers for Disease Control and Prevention· Grant· Aug 30, 2023 – Mar 25, 2026· R43PS005274
  6. OBJECTIVE OF THIS PROJECT IS TO DEVELOP A DIAGNOSTIC ASSAY FOR RAPID DETECTION OF AVIAN METAPNEUMOVIRUS (AMPV) IN LESS THAN 30 MINUTES…$174.4K
    10.212 · Small Business Innovation Research (SBIR) Program / Small Business Technology Transfer (STTR) Program· National Institute of Food and Agriculture· Project grant· Aug 11, 2025 – Mar 24, 2026· 20254000044935

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

No subawards reported as a prime in FY2026.

As a sub-recipient: who pays it · FY2026

No subawards reported to it in FY2026.

By fiscal year

  • FY2022: $0 paid out · $282.6K received
  • FY2025: $0 paid out · $127.7K received

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from FY2021.

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.